These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 25405977

  • 1. Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method.
    Xu X, Cheng S, Ding C, Lv Z, Chen D, Wu J, Zheng S.
    Mol Med Rep; 2015 Mar; 11(3):2191-8. PubMed ID: 25405977
    [Abstract] [Full Text] [Related]

  • 2. A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer.
    Wen H, Yoo SS, Kang J, Kim HG, Park JS, Jeong S, Lee JI, Kwon HN, Kang S, Lee DH, Park S.
    J Hepatol; 2010 Feb; 52(2):228-33. PubMed ID: 20036026
    [Abstract] [Full Text] [Related]

  • 3. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B, Chen D, Chen Y, Hu Z, Cao M, Xie Q, Chen Y, Xu J, Zheng S, Li L.
    J Proteome Res; 2012 Feb 03; 11(2):1217-27. PubMed ID: 22200553
    [Abstract] [Full Text] [Related]

  • 4. Exploratory investigation of plasma metabolomics in human lung adenocarcinoma.
    Wen T, Gao L, Wen Z, Wu C, Tan CS, Toh WZ, Ong CN.
    Mol Biosyst; 2013 Sep 03; 9(9):2370-8. PubMed ID: 23857124
    [Abstract] [Full Text] [Related]

  • 5. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q, Wang C, Li B.
    Appl Biochem Biotechnol; 2015 Aug 03; 176(8):2170-84. PubMed ID: 26088916
    [Abstract] [Full Text] [Related]

  • 6. Metabolomics discloses potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension.
    Seijo S, Lozano JJ, Alonso C, Reverter E, Miquel R, Abraldes JG, Martinez-Chantar ML, Garcia-Criado A, Berzigotti A, Castro A, Mato JM, Bosch J, Garcia-Pagan JC.
    Am J Gastroenterol; 2013 Jun 03; 108(6):926-32. PubMed ID: 23419380
    [Abstract] [Full Text] [Related]

  • 7. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B, García-Barrera T, Grávalos-Guzmán J, Pereira-Vega A, Gómez-Ariza JL.
    J Proteomics; 2016 Aug 11; 145():197-206. PubMed ID: 27255828
    [Abstract] [Full Text] [Related]

  • 8. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Li Y, Song X, Zhao X, Zou L, Xu G.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep 01; 966():147-53. PubMed ID: 24856296
    [Abstract] [Full Text] [Related]

  • 9. Bile Metabolites and Risk of Carcinogenesis in Patients With Pancreaticobiliary Maljunction: A Pilot Study.
    Mori H, Morine Y, Mawatari K, Chiba A, Yamada S, Saito YU, Ishibashi H, Takahashi A, Shimada M.
    Anticancer Res; 2021 Jan 01; 41(1):327-334. PubMed ID: 33419827
    [Abstract] [Full Text] [Related]

  • 10. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.
    Greenberg N, Grassano A, Thambisetty M, Lovestone S, Legido-Quigley C.
    Electrophoresis; 2009 Apr 01; 30(7):1235-9. PubMed ID: 19288586
    [Abstract] [Full Text] [Related]

  • 11. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
    Fan L, Zhang W, Yin M, Zhang T, Wu X, Zhang H, Sun M, Li Z, Hou Y, Zhou X, Lou G, Li K.
    Acta Oncol; 2012 Apr 01; 51(4):473-9. PubMed ID: 22283470
    [Abstract] [Full Text] [Related]

  • 12. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.
    Xu Y, Zheng X, Qiu Y, Jia W, Wang J, Yin S.
    J Proteome Res; 2015 Aug 07; 14(8):3315-21. PubMed ID: 26130307
    [Abstract] [Full Text] [Related]

  • 13. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer.
    Farina A, Dumonceau JM, Frossard JL, Hadengue A, Hochstrasser DF, Lescuyer P.
    J Proteome Res; 2009 Jan 07; 8(1):159-69. PubMed ID: 19055478
    [Abstract] [Full Text] [Related]

  • 14. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.
    Zhang T, Wu X, Yin M, Fan L, Zhang H, Zhao F, Zhang W, Ke C, Zhang G, Hou Y, Zhou X, Lou G, Li K.
    Clin Chim Acta; 2012 May 18; 413(9-10):861-8. PubMed ID: 22309680
    [Abstract] [Full Text] [Related]

  • 15. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X, Xu L, Shen J, Cao B, Cheng T, Zhao T, Liu X, Zhang H.
    Biochim Biophys Acta; 2013 Aug 18; 1832(8):1207-16. PubMed ID: 23524237
    [Abstract] [Full Text] [Related]

  • 16. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X, Zhong J, Wang S, Zhou Y, Wang L, Zhang Y, Yuan Y.
    Oncotarget; 2017 Apr 25; 8(17):29116-29124. PubMed ID: 28418859
    [Abstract] [Full Text] [Related]

  • 17. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions.
    Lam CW, Law CY.
    J Proteome Res; 2014 Sep 05; 13(9):4040-6. PubMed ID: 25117182
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.
    Luan H, Liu LF, Tang Z, Zhang M, Chua KK, Song JX, Mok VC, Li M, Cai Z.
    Sci Rep; 2015 Sep 14; 5():13888. PubMed ID: 26365159
    [Abstract] [Full Text] [Related]

  • 19. Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis.
    Tang YM, Wang JP, Bao WM, Yang JH, Ma LK, Yang J, Chen H, Xu Y, Yang LH, Li W, Zhu YP, Cheng JB.
    Int J Mol Med; 2015 Aug 14; 36(2):377-85. PubMed ID: 26046127
    [Abstract] [Full Text] [Related]

  • 20. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
    Alberice JV, Amaral AF, Armitage EG, Lorente JA, Algaba F, Carrilho E, Márquez M, García A, Malats N, Barbas C.
    J Chromatogr A; 2013 Nov 29; 1318():163-70. PubMed ID: 24139504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.